|
|
||||||||
Departments of 1 Pathology and 2 Medicine, Keck School of Medicine of the University of Southern California, Los Angeles 90089; 3 Veterans Affairs Greater Los Angeles Healthcare System, Sepulveda, California 91343; 4 Department of Veterans Affairs Medical Center, Omaha, Nebraska 68198; 5 Department of Medicine, University of North Carolina at Chapel Hill, North Carolina 27599-7038; and 6 Institute for Clinical Chemistry, University of Ulm, Ulm, Germany 89070
Interleukin (IL)-10 expression is
induced in activated hepatic stellate cells (HSC) in vitro and in vivo.
We analyzed expression of IL-10 receptor (IL-10R) and coreceptor
cytokine receptor family (CRF2-4) in HSC. We aimed to
clone and sequence partial cDNA for rat IL-10R and CRF2-4,
determine their expression in activated rat HSC in vivo and in vitro,
and examine the biological responsiveness of HSC to exogenous IL-10.
PCR cloning and sequencing of partial rat IL-10R and CRF2-4 cDNAs
revealed 86% homology with corresponding mouse sequences. In hepatic
macrophages, Northern blot with cloned IL-10R cDNA detected an expected
3.5-kb transcript, and IL-10R and CRF2-4 mRNAs showed steady
constitutive expression after in vitro lipopolysaccharide treatment or
cholestatic liver injury. IL-10R mRNA expression, as confirmed by
immunohistochemistry, was induced 20.1- and 8.6-fold in HSC from
cholestatic livers and 7-day culture-activated HSC, respectively but
CRF2-4 mRNA levels were unchanged. Under serum-free conditions,
IL-10 had minimal effects on collagen production but reduced DNA
synthesis, matrix metalloprotease-2 mRNA levels, and activity in HSC.
With serum, IL-10 inhibited both collagen production and DNA synthesis but had no effect on procollagen-
1(I) mRNA levels. This
shows concomitant induction of IL-10R but not CRF2-4 to that of
IL-10 by activated HSC in vitro and in vivo and associated acquisition of the responsiveness to IL-10, entailing complex effects on HSC.
interleukin-10; cytokine receptor family 2-4; procollagen-
1(I) ; matrix metalloprotease-2; matrix
metalloprotease-13; monocyte-chemoattracting protein-1; liver fibrosis
This article has been cited by other articles:
![]() |
F. Gilli, P. Valentino, M. Caldano, L. Granieri, M. Capobianco, S. Malucchi, A. Sala, F. Marnetto, and A. Bertolotto Expression and regulation of IFN{alpha}/{beta} receptor in IFN{beta}-treated patients with multiple sclerosis Neurology, December 9, 2008; 71(24): 1940 - 1947. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Horani, N. Muhanna, O. Pappo, A. Melhem, C. E. Alvarez, S. Doron, W. Wehbi, K. Dimitrios, S. L. Friedman, and R. Safadi Beneficial effect of glatiramer acetate (Copaxone) on immune modulation of experimental hepatic fibrosis Am J Physiol Gastrointest Liver Physiol, February 1, 2007; 292(2): G628 - G638. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. van de Bovenkamp, G. M. M. Groothuis, A. L. Draaisma, M. T. Merema, J. I. Bezuijen, M. J. van Gils, D. K. F. Meijer, S. L. Friedman, and P. Olinga Precision-Cut Liver Slices as a New Model to Study Toxicity-Induced Hepatic Stellate Cell Activation in a Physiologic Milieu Toxicol. Sci., May 1, 2005; 85(1): 632 - 638. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |